🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsPublic SquareNovo Nordisk CagriSema Phase 3 results — need advice Page 7

Novo Nordisk CagriSema Phase 3 results — need advice

mike_mod Tue, Nov 18, 2025 at 8:31 PM 43 replies 1,982 viewsPage 7 of 9
Dr.RaviCardio
VIP Member
2,890
15,678
Jan 2024
New York, NY
Dec 1, 2025 at 12:07 AM#31
mike_mod said:
Update — my curve sits below the published mean and the explanation is that the trial arm had support I do not have.

Careful with the causal language. Two things moving together in a period when five things changed is not a mechanism, and stating it as one makes the thread less useful to somebody reading it later.

43 18pete_manc_UK, anna.melb_AU, mark_tokyo and 40 others
Reply Quote Save Share Report
nick_SD_fit
Member
278
1,234
Sep 2024
San Diego, CA
Dec 1, 2025 at 10:03 PM#32
mike_mod said:
Update — my curve sits below the published mean and the explanation is that the trial arm had support I do not have.

Right, and the exception is worth naming rather than left implied, because the exception is where people get into trouble.

If somebody has the primary source to hand I would rather cite it than paraphrase it.

42 17Dr.CardioMD, EndoResFellow, PharmacoVig_BOS and 39 others
Reply Quote Save Share Report
amsterdam_pete
Senior Member
1,567
6,789
Feb 2024
Netherlands
Dec 2, 2025 at 8:00 PM#33
mike_mod said:
Update — my curve sits below the published mean and the explanation is that the trial arm had support I do not have.

Thank you for spelling out the reasoning rather than just the conclusion. I will report back once I have actually tried it.

41 16CanadaChris, ZaraB_AL, JakeSmashed95 and 38 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
Dr.SurgeonPGH
Senior Member
1,345
6,789
Mar 2024
Pittsburgh, PA
Dec 3, 2025 at 5:57 PM#34

Clinical perspective, offered as context rather than as advice. Whatever the answer turns out to be, the method for getting there is the same: state the assumption, do the arithmetic in public, and invite the correction. That is slower than asserting, and it is the only version that survives being wrong.

40 15RickReta_CO, PharmHunterJen, TomTeleRx and 37 others
Reply Quote Save Share Report
claudia_zurich
Member
389
1,678
Jul 2024
Zurich, CH
Dec 4, 2025 at 3:55 PM#35
Dr.SurgeonPGH said:
Whatever the answer turns out to be, the method for getting there is the same: state the assumption, do the arithmetic in public, and invite the…

This is my experience too, for whatever a second data point is worth. Posting only so the count is not one.

39 14kevin_tulsa, Dr.PainCLE, mike_mealprep and 36 others
Reply Quote Save Share Report

Similar Threads

SELECT trial 4-year follow-up data released — sustained MACE reduction16 replies
GLP-1 receptor agonists and thyroid C-cell concerns — evidence review19 replies
Is there a ceiling effect for GLP-1-mediated weight loss?20 replies
Comparative pharmacokinetics: semaglutide vs tirzepatide vs retatrutide6 replies
My 18-month semaglutide journey — comprehensive data log20 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register